Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Jan. 13, 1998

Chemogene therapy: a new therapeutic approach on the horizon?

Jan. 13, 1998

CDK inhibitor induces apoptosis and tumor necrosis in a dog with malignant melanoma

Jan. 12, 1998

FDA approves Photofrin for early-stage lung cancer

Jan. 12, 1998

New mycotoxin with antitumor and favorable hematological effects

Jan. 12, 1998

Good in vitro activity reported for Novartis PKC inhibitor

Jan. 12, 1998

Merck continues to devote extensive R&D efforts to FTase inhibitors

Jan. 12, 1998

New phosphatase inhibitors from the University of Pittsburgh

Jan. 9, 1998

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

Jan. 9, 1998

New vitamin D conjugates disclosed by Clarion

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...